In this clinical trial we will investigate how safe the study compound is and how well it is tolerated when it is used by healthy participants. We will also investigate how quickly and to what extent the study compound is absorbed, transported and eliminated by the body (this is called pharmacokinetics).
The study compound could potentially be used for the treatment of worsening heart failure. With worsening heart failure, the heart cannot pump the blood well enough anymore, resulting in blood and fluid collecting in the lungs and legs. Worsening of chronic heart failure is usually treated with diuretics, which are medicines that help reduce fluid buildup in the body, but do not fully resolve the congestion leaving the patients at risk of suffering new episodes of worsening heart failure and subsequent hospitalization. The study compound is aimed to relax the blood vessels, improve functioning of the heart and help the kidneys to remove water and salt.